Fabio Cacciapaglia

36PUBLICATIONS
145CO-AUTHORS
PharmacogenomicsPredictive and prognostic markersRheumatology and arthritisMolecular targetsAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Sep 07, 2026
Selexipag in systemic sclerosis-associated pulmonary arterial hypertension: long-term real-world data from a multicentre Italian cohort.

|Aug 28, 2026
Cancer in Systemic Sclerosis: Clinical Associations and Prognostic Impact From the EUSTAR Registry.

|Jul 30, 2026
Concurrent initiation of tirzepatide and biologics improves patient-reported outcomes in obese psoriatic arthritis: a propensity score-matched study.

|Jul 08, 2026
Dermatomyositis is characterized by TYK2-dependent STAT3 activation.

|Jun 09, 2026
Safety and effectiveness of tocilizumab in systemic sclerosis: a multicentre French-Italian study.

|May 13, 2026
Clinical and serological features of triple autoantibody-negative patients with systemic sclerosis: insights from the multicentric SPRING registry of the Italian Society for Rheumatology.

Pageof 6

Frequent Collaborators

20 joint publications

Florenzo Iannone

9 joint publications

Maria De Santis

8 joint publications

Giacomo De Luca

8 joint publications

Corrado Campochiaro